In this preprint by Ng et al., binding IgG antibodies to conserved epitopes from SARS-CoV-2 S and N proteins were detected by flow cytometry and ELISA in approximately 10% of healthy individuals with a recent history of infection by human endemic coronaviruses (HCoVs). Of note, sera from the same donors were found to have SARS-CoV-2 neutralization activity comparable to that of samples from seropositive patients with COVID-19, which suggests that cross-neutralizing antibodies developed in response to previous HCoV exposure might interfere with SARS-CoV-2 entry into target cells. Further studies are needed to assess the potentially protective role of pre-existing cross-reactive antibodies in healthy individuals in the context of COVID-19 immunopathogenesis.
References
Original article
Ng, K. et al. Pre-existing and de novo humoral immunity to SARS-CoV-2 in humans. Preprint at bioRxiv https://doi.org/10.1101/2020.05.14.095414 (2020)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
van der Heide, V. SARS-CoV-2 cross-reactivity in healthy donors. Nat Rev Immunol 20, 408 (2020). https://doi.org/10.1038/s41577-020-0362-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41577-020-0362-x